The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer

Published:2013-12-23 Issue:2 Volume:34 Page:199-208
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hayashi H,Arao T,Togashi Y,Kato H,Fujita Y,De Velasco M A,Kimura H,Matsumoto K,Tanaka K,Okamoto I,Ito A,Yamada Y,Nakagawa K,Nishio K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2013547.pdf

Reference39 articles.

1. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P . New type of POU domain in germ line-specific protein Oct-4. Nature 1990; 344: 435–439.

2. Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676.

3. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW . OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008; 26: 3068–3074.

4. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H . POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006; 24: 2685–2691.

5. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR . OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007; 120: 1598–1602.

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting transposable elements in cancer: developments and opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation;Endocrine;2024-08-13

3. Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer;Genes & Diseases;2024-05

4. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature;Frontiers in Immunology;2024-05-01

5. Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkers;Pathology - Research and Practice;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3